CRLF2 rearrangement could also cause Philadelphia chromosome-like (Ph-like) ALL, a high-risk phenotype with resistance to traditional chemotherapy and poor outcomes (64, 66). The gene discussed is CRLF2; the disease is acute lymphoblastic leukemia.